GreenLight Biosciences Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 283
Employees
  • Stock Symbol
  • GRNA
Stock Symbol
  • Share Price
  • $10.77
  • (As of Thursday Closing)

GreenLight Biosciences General Information

Description

GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Specialty Chemicals
Stock Exchange
NAS
Primary Office
  • 200 Boston Avenue
  • Suite 1000
  • Medford, MA 02155
  • United States
+1 (888) 000-0000

GreenLight Biosciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GreenLight Biosciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.77 $10.02 $4.83 - $15.80 $1.23B 123M 346K -$0.92

GreenLight Biosciences Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 0 962 3,001
EBITDA (89,067) (50,552) (28,509)
Net Income (95,126) (53,251) (28,649)
Total Assets 63,292 113,828 30,609
Total Debt 38,816 18,898 1,572
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GreenLight Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.

Request a free trial

GreenLight Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.

Request a free trial

GreenLight Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic
Biotechnology
Medford, MA
283 As of 2022
00000
000000000 00000

000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

000 0000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
000000000 000000000
Boulder, CO
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GreenLight Biosciences Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
000 00000000000000 Venture Capital-Backed Boulder, CO 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Lutherville Timonium, MD 0 000.00 0000000000 0 000.00
0000000 Formerly VC-backed Lebanon, NH 00 000.00 000000&0 000.00
0000000 Corporation Roslin, United Kingdom 0 0000000000
You’re viewing 5 of 16 competitors. Get the full list »

GreenLight Biosciences Patents

GreenLight Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210068402-A1 Methods and compositions for control of arthropod pests Pending 05-Sep-2019 0000000000
CA-3135368-A1 Cell-free production of ribonucleic acid Pending 29-Mar-2019 0000000000
AU-2020253354-A1 Cell-free production of ribonucleic acid Pending 29-Mar-2019 0000000000
EP-3899006-A2 Cell-free production of allulose Pending 21-Dec-2018 00000000
CA-3123590-A1 Cell-free production of allulose Pending 21-Dec-2018 C07H3/02
To view GreenLight Biosciences’s complete patent history, request access »

GreenLight Biosciences Executive Team (10)

Name Title Board Seat Contact Info
Andrey Zarur Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Susan Keefe Chief Financial Officer, Finance
Carole Cobb Chief Operating Officer, Operations
Amin Khan Ph.D Chief Scientific Officer
Charu Manocha Executive
You’re viewing 5 of 10 executive team members. Get the full list »

GreenLight Biosciences Board Members (19)

Name Representing Role Since
Andrey Zarur Ph.D GreenLight Biosciences Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Charles Cooney Ph.D Self Board Member 000 0000
Colin Steen Syngenta Group Ventures Board Member 000 0000
David Furneaux Kodiak Venture Partners Board Member 000 0000
Eric O'Brien Fall Line Capital Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

GreenLight Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GreenLight Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.

Request a free trial